Aflibercept ophthalmic Interactions
No drug interactions were found for aflibercept ophthalmic. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Aflibercept ophthalmic is in the drug class anti-angiogenic ophthalmic agents. Aflibercept ophthalmic is used to treat the following conditions: Diabetic Macular Edema, Diabetic Retinopathy, Macular Degeneration, Macular Edema, Macular Edema Following Retinal Vein Occlusion, Retinopathy of Prematurity.
Aflibercept ophthalmic disease interactions
There is 1 disease interaction with aflibercept ophthalmic which include:
More about aflibercept ophthalmic
- aflibercept ophthalmic consumer information
- Compare alternatives
- Reviews (78)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.